| Patent No. | Patent Title: |
| 4997645 | Methods and pharmaceutical composition for the treatment of tumor... |
| 4962035 | DNA encoding IgE receptor alpha-subunit or fragment thereof |
| 4961969 | Process for recovering microbially produced interferon-ଲ |
| 4959210 | Treatment of genital warts with a combination of liquid nitrogen ... |
| 4957906 | Pharmaceutical compositions containing a derivative of para-amino... |
| 4957733 | Pharmaceutical products |
| 4957734 | Treatment of certain skin malignancies and pre-malignant skin les... |
| 4956349 | Anti-inflammatory factor, method of isolation, and use |
| 4954449 | Human monoclonal antibody reactive with polyribosylribitol phosph... |
| 4950470 | Methods and compositions employing interferon-gamma |
| 4948730 | Modulation of animal cellular responses with compositions contain... |
| 4946674 | Process for treatment of rheumatic diseases |
| 4944941 | Methods and compositions for the treatment of lung conditions |
| 4939088 | Sustained production of recombinant gamma interferon using an ... |
| 4935233 | Covalently linked polypeptide cell modulators |
| 4929442 | Compositions suitable for human topical application including a g... |
| 4929443 | Method of treating interferon sensitive diseases, and a method an... |
| 4925831 | Aminoalkyl naphthalenediols as host resistance enhancers against ... |
| 4923852 | Aminoalkyl naphthalenediols as host resistance enhancers against ... |
| 4921697 | IFN-gamma as an active substance for inhibiting and preventing ... |
| 4921698 | Polypeptide having gamma-interferon activity lacking amino acids ... |
| 4921699 | Polypeptides having interferon activity |
| 4920209 | Oral vaccines |
| 4917887 | Hybrid interferons, their use as pharmaceutical compositions and ... |
| 4917888 | Solubilization of immunotoxins for pharmaceutical compositions us... |
| 4915941 | Method for preventing the development or decreasing the extent of... |
| 4915944 | Novel isolate of trichoderma, fungicidal compositions containing ... |
| 4914033 | Structure and properties of modified interferons |
| 4911908 | Interferon administration vehicles |
| 4908432 | Novel polypeptide having gamma-interferon activity |
| 4902506 | Immunogenic conjugates |
| 4902505 | Chimeric peptides for neuropeptide delivery through the blood-bra... |
| 4898818 | Antitumor active substance, process for preparing the same, drug ... |
| 4898931 | Novel human interferon-γ polypeptide derivative |
| 4897265 | Method for treating disorders of the vascular and pulmonary syste... |
| 4897471 | Consensus human leukocyte interferon |
| 4895937 | 5-ioso-2-pyrimidinone nucleoside |
| 4895716 | Stabilized formulations of gamma interferons |
| 4894330 | Purification of recombinant beta-interferon incorporating RP-HPLC |
| 4894226 | Solubilization of proteins for pharmaceutical compositions using ... |